[1] |
Cho MS, Kim SH, Park SW, et al. Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience[J]. J Gastrointest Surg, 2012, 16(9):1672-1679.
|
[2] |
Sang H, Li T, Li H, et al. Down-regulation of Gab1 inhibits cell proliferation and migration in hilar cholangiocarcinoma[J]. PLoS One, 2013, 8(11):e81347.
|
[3] |
Xiong JJ, Nunes QM, Huang W, et al. Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy[J]. World J Gastroenterol, 2013, 19(46):8731-8739.
|
[4] |
Robles R, Sánchez-Bueno F, Ramírez P, et al. Liver transplantation for hilar cholangiocarcinoma[J]. World J Gastroenterol, 2013, 19(48):9209-9215.
|
[5] |
Gomez D, Patel PB, Lacasia-Purroy C, et al. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma[J]. Eur J Surg Oncol, 2014, 40(1):77-84.
|
[6] |
陈连周,李运泉,司徒妙琼,等.利用组织芯片分析肝细胞肝癌中Caspase-9与Ki-67的表达及意义[J].中国医药,2008, 3(11):657-658.
|
[7] |
Pez F, Lopez A, Kim M, et al. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs[J]. J Hepatol, 2013, 59(5):1107-1117.
|
[8] |
Figueira AC, Gomes C, Vilhena H, et al. Characterization ofα-, β- and p120-Catenin Expression in Feline Mammary Tissues and their Relation with E- and P-Cadherin[J]. Anticancer Res, 2015, 35(6):3361-3369.
|
[9] |
Hammond E, Lang J, Maeda Y, et al. The Wnt effector transcription factor 7-like 2 positively regulates oligodendrocyte differentiation in a manner independent of Wnt/β-catenin signaling[J]. J Neurosci, 2015, 35(12):5007-5022.
|
[10] |
Yu M, Ting DT, Stott SL, et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis[J]. Nature, 2012, 487(7408):510-513.
|
[11] |
Quan MF, Xiao LH, Liu ZH, et al. 8-Bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin[J]. World J Gastroenterol, 2013, 19(43):7680-7695.
|
[12] |
Moossavi S. Location-specific effect of microbiota and MyD88-dependent signaling on Wnt/β-catenin pathway and intestinal stem cells[J]. Gut Microbes, 2014, 5(1):11-14.
|
[13] |
Omur O, Baran Y. An update on molecular biology of thyroid cancers[J]. Crit Rev Oncol Hematol, 2014, 90(3):233-252.
|
[14] |
Nigam A. Breast cancer stem cells, pathways and therapeutic perspectives 2011[J]. Indian J Surg, 2013, 75(3):170-180.
|
[15] |
Wang S, Bao Z, Liang QM, et al. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator [J]. Hepatogastroenterology, 2013, 60(127):1639-1646.
|
[16] |
Sun Y, Fan L, Meng J, et al. Should GLP-1 receptor agonists be used with caution in high risk population for colorectal cancer?[J]. Med Hypotheses, 2014, 82(3):255-256.
|
[17] |
Zheng Q, Zhang Y, Ren Y, et al. Antiproliferative and apoptotic effects of indomethacin on human retinoblastoma cell line Y79 and the involvement of β-catenin, nuclear factor-κB and Akt signaling pathways[J]. Ophthalmic Res, 2014, 51(2):109-115.
|
[18] |
Warrier S, Balu SK, Kumar AP, et al. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells[J]. Oncol Res, 2013, 21(2):93-102.
|
[19] |
Piao J, Nakatsu Y, Ohno M, et al. Mismatch repair deficient mice show susceptibility to oxidative stress-induced intestinal carcinogenesis[J]. Int J Biol Sci, 2013, 10 (1):73-79.
|
[20] |
Zhi X, Tao J, Xie K, et al. MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer[J]. Cancer Lett, 2014, 346(1):104-113.
|